# REZLIDHIA
> **NDA215814** · New Drug Application · Sponsor: RIGEL PHARMS · Approved 2022-12-01
## Drug
- **FDA Application Number:** NDA215814
- **Application type:** New Drug Application
- **Brand name:** REZLIDHIA
- **Generic name:** OLUTASIDENIB
- **Active ingredients:** OLUTASIDENIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RIGEL PHARMS
- **Manufacturer:** Rigel Pharmaceuticals, Inc.
- **First approval:** 2022-12-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215814)
---
*AI Analytics · CC0 1.0*